Search images on Google Product Monograph
Active Ingredients:
- bevacizumab, 25 MG/ML
DIN: 02470756
Dosage Form(s): SOLUTION
Route(s) of Administration: INTRAVENOUS
Description: 400 MG/16 ML.SINGLE-USE VIAL.
Schedule: Prescription
Company: AMGEN CANADA INC
ATC:
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
- L01F - (ATC, WHO)
- L01FG - (ATC, WHO)
- L01FG01 - BEVACIZUMAB (WHO)